XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
No Par, Common Stock
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period at Dec. 31, 2019 $ 42,725 $ 91,816 $ (49,580) $ 489
Balance at beginning of period (in shares) at Dec. 31, 2019   9,592,861    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (2,679)   (2,679)  
Repurchase of common stock (35) $ (35)    
Repurchase of common stock (in shares)   (11,211)    
Restricted stock unit expense, net 636 $ 636    
Restricted stock unit expense, net (in shares)   96,813    
Other comprehensive income (loss) 1,939     1,939
Balance at end of period at Sep. 30, 2020 42,586 $ 92,417 (52,259) 2,428
Balance at ending of period (in shares) at Sep. 30, 2020   9,678,463    
Balance at beginning of period at Jun. 30, 2020 43,280 $ 92,275 (52,800) 3,805
Balance at beginning of period (in shares) at Jun. 30, 2020   9,598,155    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 541   541  
Repurchase of common stock (19) $ (19)    
Repurchase of common stock (in shares)   (6,505)    
Restricted stock unit expense, net 161 $ 161    
Restricted stock unit expense, net (in shares)   86,813    
Other comprehensive income (loss) (1,377)     (1,377)
Balance at end of period at Sep. 30, 2020 42,586 $ 92,417 (52,259) 2,428
Balance at ending of period (in shares) at Sep. 30, 2020   9,678,463    
Balance at beginning of period at Dec. 31, 2020 44,413 $ 92,486 (48,985) 912
Balance at beginning of period (in shares) at Dec. 31, 2020   9,681,728    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (293)   (293)  
Repurchase of common stock (11) $ (11)    
Repurchase of common stock (in shares)   (3,547)    
Stock-based compensation expense 184 $ 184    
Stock-based compensation expense, Shares   27,975    
Other comprehensive income (loss) (2,185)     (2,185)
Balance at end of period at Sep. 30, 2021 42,108 $ 92,659 (49,278) (1,273)
Balance at ending of period (in shares) at Sep. 30, 2021   9,706,156    
Balance at beginning of period at Jun. 30, 2021 43,884 $ 92,612 (48,069) (659)
Balance at beginning of period (in shares) at Jun. 30, 2021   9,689,421    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (1,209)   (1,209)  
Repurchase of common stock (4) $ (4)    
Repurchase of common stock (in shares)   (1,240)    
Stock-based compensation expense 51 $ 51    
Stock-based compensation expense, Shares   17,975    
Other comprehensive income (loss) (614)     (614)
Balance at end of period at Sep. 30, 2021 $ 42,108 $ 92,659 $ (49,278) $ (1,273)
Balance at ending of period (in shares) at Sep. 30, 2021   9,706,156